|Nanosonics Limited -- Australia Stock|| |
AUD 2.76 0.02 0.72%
Head of Global Services
Mr. Vincent Wang is Head of Global Customer Support and Technical Services of Nanosonics Limited
61 2 8063 1600 http://www.nanosonics.com.au
Wang has extensive experience in developing and implementing global service and support strategy, establishing and managing customer support, technical service and service marketing functions in global medical device businesses. Prior to joining Nanosonics in May 2011, Mr. Wang spent 11 years leading and managing the Technical Support, Services Repair and Customer Service Operations for Sonova Hearing Healthcare Group and Cochlear Ltd.
The company has return on total asset (ROA)
of 9.03 %
which means that it generated profit of $9.03 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 36.35 %
meaning that it generated $36.35 on every $100 dollars invested by stockholders.
The company has accumulated 1.35 M in total debt with debt to equity ratio (D/E) of 1.5 which is about average as compared to similar companies. Nanosonics Limited has Current Ratio of 8.7 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Nanosonics Limited, together with its subsidiaries, engages in the research, development and commercialization of infection control and decontamination solutions and related technologies. Nanosonics Limited (NAN) is traded on Australian Securities Exchange in Australia. It is located in Lane Cove West, NSW and employs 150 people.